Testing effectiveness (Phase 2)Looking for participantsNCT04732416
What this trial is testing
HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)
Who this might be right for
Congenital Hyperinsulinism
Hanmi Pharmaceutical Company Limited 16